SMS. D. Malkov

S. D. Malkov

*This is an algorithmically generated author record based on publicly available information.

S. D. Malkov has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Elena Flisyuk

    Department of Pharmaceutical Formulations, St. Petersburg State Chemical Pharmaceutical University, 14a Prof. Popov Str., 197022 Saint-Petersburg, Russia

    4 shared publications
  • Yu. M. Kotsur

    Saint-Petersburg State Chemical and Pharmaceutical University

    4 shared publications
  • Ю. М. Коцур

    Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)

    4 shared publications
  • K. O. Zarifi

    Saint-Petersburg State Chemical and Pharmaceutical University

    3 shared publications
  • Aleksandr Nikolayevich Shikov

    Department of Pharmaceutical Formulations, St. Petersburg State Chemical Pharmaceutical University, 14a Prof. Popov Str., 197022 Saint-Petersburg, Russia

    2 shared publications
  • E. K. Krasova

    Saint-Petersburg State Chemical and Pharmaceutical University

    2 shared publications

Latest Publications

  • Open Access

    An investigation into the effect of polymer components on the physicochemical and mechanical properties of hemostatic sponges

    by S. D. Malkov, Yu. M. Kotsur, E. V. Flisyuk, С. Д. Малков, Ю. М. Коцур, Е. В. Флисюк

    Introduction. Sponges are the most widely used form of topical hemostatic agents. Regulatory requirements for sponges are often incomplete and do not cover some properties, especially at the pharmaceutical development stage. Aim. To evaluate the effect of polymers on the properties of hemostatic sponges. Materials and methods. The study used sodium carboxymethylcellulose (Na-CMC), sodium alginate, polyethylene glycol (PEG-6000), and a copolymer of methacrylic acid and ethyl acrylate (CMAEA). Samples were prepared by freeze-drying and evaluated for appearance, density, porosity, absorption capacity, swelling ratio, and swelling kinetics. Data normalization was performed to compare the results. Results and discussion. The appearance of the samples depended on the starting component. An increase in component concentration led to higher sponge density. Maximum porosity was observed in compositions containing 3 % PEG-6000 or CMAEA. The matrix-forming components showed similar absorption capacity, while the addition of synthetic polymers reduced this parameter. The swelling ratio decreased in the order Na-CMC > sodium alginate > PEG-6000/CMAEA, and the composition with 1 % Na-CMC showed the maximum swelling ratio. Conclusion. The effect of sponge components on appearance, density, porosity, absorption capacity, swelling ratio, and swelling kinetics was considered. The nature of the effect of individual components on specific physicochemical and mechanical properties of the sponges was determined. The results can be used to justify the choice of excipients in the development of hemostatic sponges.

  • Open Access

    Optimisation of technological parameters for production of lipid nanoparticles for delivery of mRNA

    by Yu. M. Kotsur, S. D. Malkov, K. O. Zarifi, K. A. Gusev, D. N. Maimistov, E. V. Flisyuk, I. A. Narkevich, Ю. М. Коцур

    Introduction. Gene therapy is actively developing through the use of mRNA agents for the treatment and prevention of various diseases. To manifest a therapeutic effect, it is necessary to deliver mRNA to target cells and induce the synthesis of target proteins. Key challenges include developing safe and efficient delivery systems. The critical quality attributes for lipid nanoparticles are average particle size, polydispersity index, and ζ potential. Aim. To study and optimize the assembly conditions of lipid nanoparticles to control their basic characteristics. Materials and methods. Ionizable lipid heptadecan-9yl(Z)-N-((4-dimethylamino)butyl)thio)carbonyl)-N-(2-(non-2-en-1-yloxy)-2-oxoethyl)glycinate (IL) and helper lipids – dipalmitoylglierophosphate (DPPC), cholesterol, and a-(3"-[1,2-di (myristyloxy) propanoxy]carbonylamino}propyl)-w-methoxypolyoxyethylene (DMG-PEG2000). Solvents: absolute alcohol, purified water. Buffer solutions: acetate buffer solution (pH 4.5), phosphate buffer solution (pH 7.4). Equipment: microfluidic installation Dolomite (Dolomite Microfluidics, Великобритания), Y-shaped polymer microfluidic chip with passive micromixer type "tesla coil", Nanosizer Zeta Pro nanoscale particle analyzer (LLC "Microtrack", Russia). Results and discussion. The study examined the effects of TFR and FRR parameters on LNF properties. Characteristics such as hydrodynamic diameter (Z-average), average particle diameter (D50), polydispersity index (PDI) and ζ potential were analyzed. The study confirms that with increasing FRR, the average hydrodynamic and median particle sizes decrease. Increasing TFR also decreases Z-average and D50 through hydrodynamic focusing, but at TFR = 3200 μl/min, particle size increases due to decreased nanoemulsion stability and fine particle aggregation. The study did not reveal a direct relationship between FRR and PDI. Nanoemulsions with FRRs of 1 : 3 and 1 : 4 showed the greatest homogeneity. As TFR increases, the polydispersity of the nanoparticles decreases. In the study, the dependence of the ζ potential of lipid nanoparticles on the estimated process parameters was not found. However, as TFR increases, the ζ potential tends to increase. Conclusion. In the study, the conditions for assembling lipid nanoparticles (LNP) using the microfluidic method were optimized. Mathematical models are proposed to control characteristics of nanoparticles. Optimal conditions for producing LNP: FRR = 1 : 3; 1 : 4; TFR 2000 to 3000 µL/min. If FRR = 1 : 5 and/or TFR > 3000 µL/min are used, the values may be outside the optimal range, which requires additional risk assessment.

  • Open Access

    Liposomes – metabolically active drug transport systems: visualization and pharmacokinetic. Part 2 (review)

    by O. N. Pozharitskaya, Yu. M. Kozur, S. S. Osochuk, E. V. Flisyuk, I. E. Smekhova, S. D. Malkov, K. O. Zarifi, I. A. Titovich, E. K. Krasova, A. N. Shikov, et al.

    Introduction. In the second part of the review we discussed aspects of visualization, pharmacokinetics and biodistribution of liposomes.Text. Many different methodsh as been proposed for the visualization of liposoms morphology and quality such as light microscopy, ESEM, TEM, AFM, etc. Each method have own advantages and limitations which are discussed in the article: In general, the selection of method depends on the specific morphological characteristics and level of details. It is important to understand the specificity of the liposomes and the visualization method for correct preparation of samples. Adequately performed pharmacokinetic and biodistribution studies can also be used as a tool for liposome visualization. The nature of active pharmaceutical ingredients, dose, lipid components, size of liposomes, charge, coating of liposomes with excipients and route of administration significantly affects the pharmacokinetics of liposomal forms. Additionally, the interaction of liposomal forms with the immune system, reticuloendothelial system and blood components play an important role in their absorption, distribution and elimination.Conclusion. The better understanding of the absorption, biodistribution, metabolism and clearance of liposomal formulations is essential for the development of modern drugs.


  • Open Access

    Liposomes – metabolically active drug transport systems: classification, components, preparation methods, and stabilization. Part 1 (review)

    by S. S. Osochuk, Yu. M. Kotsur, O. N. Pozharitskaya, E. V. Flisyuk, I. E. Smekhova, S. D. Malkov, K. O. Zarifi, I. A. Titovich, E. K. Krasova, A. N. Shikov, et al.

    Introduction. This review article is focused on the modern classification of liposomes, preparation methods, stabilization and the role of structural components, visualization, and pharmacokinetics. Part 1 discusses the first three aspects mentioned above.Text. Depending on the size and number of bilayers, liposomes are classified into simple, long-circulating, cationic, immuno-liposomes, and sterically stabilized. The lipid components of liposomes can have a pronounced effect on target organs and tissues. Metabolites of the main components of liposomes have their biological activity, depending on their combination and dosage. All of the above indicates the promise of using liposomes not only as carriers of drugs but also as independent effectors that can have a significant impact on human metabolism in various diseases. The advantages and limitations of methods for preparing liposomes, and the features for manufacturing stealth liposomes are discussed. A special section of the article is dedicated to liposome stabilization.Conclusions. The information discussed in the review article may be useful in the development of pharmaceutical formulations in liposomes. Liposomes are not only promising nanocontainers for targeted drug delivery, but also metabolically active complexes with a wide spectrum of activity.